Qtern is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Qtern is considered an adjunct treatment to diet and exercise. Qtern is a combination drug composed of the drugs Dapagliflozin and Saxagliptin. You may be a candidate for Qtern if you are already taking Dapagliflozin and Saxagliptin, or if you are taking Dapagliflozin and still have uncontrolled blood glucose levels.
Dapagliflozin is a sodium-glucose transporter 2 (SGLT2). Dapagliflozin is believed to work by causing excess glucose to be eliminated in the urine. Saxagliptin is a dipeptidyl peptidase 4 (DPP-4) inhibitor. Saxagliptin is believed to work by lowering blood glucose levels when they are elevated.
How do I take it?
Prescribing information states that Qtern is generally taken once daily.
Qtern comes in tablet form.
The FDA-approved label for Qtern lists common side effects including cold symptoms, urinary tract infection, and increased cholesterol or other blood lipids.
Rare but serious side effects listed for Qtern include pancreatitis, heart failure, low blood pressure, ketoacidosis (a serious condition involving high levels of acid in the blood), kidney problems, increased risk for bladder cancer, bullous pemphigoid (an inflammatory skin condition that causes blistering), and systemic allergic reaction.
For more details about this treatment, visit:
Qtern – AstraZeneca
New Combo Drugs Control Diabetes – Diabetes Forecast